Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Geovax Labs Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GOVX
Nasdaq
8731
https://www.geovax.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Geovax Labs Inc
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
- Apr 4th, 2024 4:30 pm
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
- Mar 28th, 2024 1:00 pm
GeoVax to Present at the 36th Annual Roth Conference
- Mar 12th, 2024 1:00 pm
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
- Mar 6th, 2024 2:00 pm
GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript
- Mar 2nd, 2024 1:45 pm
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
- Feb 29th, 2024 9:00 pm
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
- Feb 22nd, 2024 2:00 pm
GeoVax to Present at the 2024 BIO CEO & Investor Conference
- Feb 19th, 2024 2:00 pm
GeoVax Announces Multiple Patent Issuances and Allowances
- Feb 13th, 2024 2:00 pm
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
- Feb 6th, 2024 2:00 pm
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
- Jan 29th, 2024 2:00 pm
GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
- Jan 8th, 2024 2:00 pm
GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
- Jan 4th, 2024 2:00 pm
GeoVax Announces Issuance of Malaria Vaccine Patent
- Jan 3rd, 2024 2:00 pm
GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024
- Dec 27th, 2023 2:00 pm
GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox
- Dec 19th, 2023 2:00 pm
Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
- Dec 5th, 2023 12:00 pm
GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress
- Nov 30th, 2023 9:30 pm
GeoVax to Participate in Upcoming December Investor Events
- Nov 29th, 2023 2:00 pm
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
- Nov 28th, 2023 2:00 pm
Scroll